In May, more than 40 state attorneys general filed a lawsuit accusing pharma companies of engaging in anti-competitive practices to drive up the cost of generics. (Photo: Shutterstock)
Insurance giant Humana is taking drugmakers to court, alleging a price-fixing scheme that has driven up costs for insurers and patients alike.
Humana is accusing 37 generic drug manufacturers of colluding to set prices, in violation of antitrust laws.
"They leveraged the culture of cronyism in the generic drug industry to avoid price erosion, increase prices for targeted products, and maintain artificially inflated prices across their respective product portfolios without triggering a 'fight to the bottom' among competitors," Humana claims in its suit, which it filed last week in the U.S. District Court for the Eastern District of Pennsylvania.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
